Press Releases

SAN DIEGO, July 12, 2019 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, today announced that its collaborator Janssen Biotech, Inc. (Janssen) has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration for the subcutaneous delivery of DARZALEX

Read more...

RARITAN, N.J., July 12, 2019 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) seeking approval of a new subcutaneous (SC) formulation of DARZALEX® (daratumumab), an intravenous (IV) treatment approved for certa

Read more...

HEZHOU, China, July 12, 2019 /PRNewswire/ -- The First World Longevity Forum and Life Science Conference (WLF&LSC), organized by Hezhou Municipal People's Government, opened on Friday in Hezhou city, south China's Guangxi Zhuang Autonomous Region.The WLF&LSC aims to build a longevity cit

Read more...

ATLANTA, July 12, 2019 /PRNewswire/ -- Sharecare, the digital health company that helps people manage all their health in one place, and Quest Diagnostics (NYSE: DGX) have formed a collaboration designed to improve digital health and disease management for a range of health care consumers. Sharecare has named Quest its preferred laboratory partner for its comprehe

Read more...

SAN ANTONIO, July 12, 2019 /PRNewswire/ – At the 61st American Association of Physicists in Medicine (AAPM) Annual Meeting & Exhibition, July 14 - 18 in San Antonio, Elekta (EKTA-B.ST) will feature advanced quality assurance (QA) and treatment planning solutions that simplify the delivery of ra

Read more...

SEATTLE, July 12, 2019 /PRNewswire/ -- JND Legal AdministrationA Settlement has been reached in a class action lawsuit, In re USC Student Health Center Litigation (No. 2:18-cv-04258-SVW), involving Dr. George M. Tyndall, a gynecologist at the University of Southern California

Read more...

HAUPPAUGE, N.Y., July 12, 2019 /PRNewswire/ -- Today, United Rheumatology (UR) announced the appointment of Patrick Murphy as Chief Financial Officer.  With over two decades of experience in healthcare and finance, Patrick most recently served as the CFO at CleanSlate Centers, where he was instrumental in the early stages of devel

Read more...

WASHINGTON, July 12, 2019 /PRNewswire/ -- With the majority of 510(k) submissions having major deficiencies or being rejected the first time, scientific and regulatory experts TSG Consulting recommend that manufacturers schedule a Pre-Submission (Pre-Sub) meeting with the FDA to improve the likel

Read more...

EMERYVILLE, Calif., July 12, 2019 /PRNewswire/ -- Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced that it plans to participate in the following upcoming investor conference in August 2019.

Read more...

NASDAQ, TSX: NVCN VANCOUVER, July 12, 2019 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, today announced that the Food and Dr

Read more...